Faster global financial news!
Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
Adarx Pharmaceuticals Inc., a San Diego-based late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering on Thursday. The company priced its shares at the top of its marketed range, selling 26.25 million shares for $17 each.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
Reviewing Bitcoin's Historical Performance Amid Geopolitical Conflicts: From Flash Crash to V-Shaped Recovery—True Safe-Haven Asset or High Volatility?
-
2
What is Computing Power? A Comprehensive Analysis from Concept to Market
-
3
DNT Issue Price at 0.1 Yuan? Current Status and Risks of district0x
-
4
Verification of DOGEBLUE Coin Purchase Channels and Long-Term Holding Risk Analysis
-
5
Current Status and Long-Term Investment Value Analysis of TajCoin (TAJ)
-
6
What is Cryptocurrency? A Review of the Top 5 Cryptocurrencies by Market Cap in 2026
-
7
What is the value of the JavaScript token? Is it worth a long-term investment?
-
8
1MIL Token Analysis: Project Positioning and High-Risk Attributes
-
9
How to Trade KRX Tokens? Current Listed Exchanges and Risk Warnings
-
10
What is TBX? Current Status of Tokenbox Tokens and Trading Channels
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
